Publications by authors named "Bruno Tigani"

22Publications

Targeting interleukin-4 to the arthritic joint.

J Control Release 2020 Oct 10;326:172-180. Epub 2020 Jul 10.

Institute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, Germany. Electronic address:

View Article and Find Full Text PDF
October 2020

1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats.

Drug Metab Dispos 2014 Jul 11;42(7):1117-24. Epub 2014 Apr 11.

Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (R.A.S., E.W., P.L., S.M., B.S.); and Global Imaging Group, Novartis Pharma AG, Basel, Switzerland (B.T.).

View Article and Find Full Text PDF
July 2014

Hyaluronidase modulates bleomycin-induced lung injury detected noninvasively in small rodents by radial proton MRI.

J Magn Reson Imaging 2015 Mar 13;41(3):755-64. Epub 2014 Mar 13.

Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland; University of Basel, Biocenter, Basel, Switzerland.

View Article and Find Full Text PDF
March 2015

Adriamycin-induced nephropathy in rats: functional and cellular effects characterized by MRI.

J Magn Reson Imaging 2015 Mar 5;41(3):829-40. Epub 2014 Mar 5.

Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland; University of Basel, Biocenter, Basel, Switzerland.

View Article and Find Full Text PDF
March 2015

Lung MRI for experimental drug research.

Eur J Radiol 2007 Dec 10;64(3):381-96. Epub 2007 Oct 10.

Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
December 2007

Lung inflammation and vascular remodeling after repeated allergen challenge detected noninvasively by MRI.

Am J Physiol Lung Cell Mol Physiol 2007 Mar 3;292(3):L644-53. Epub 2006 Nov 3.

Discovery Technologies Department, Novartis Institutes for BioMedical Research, Basel, Switzerland.

View Article and Find Full Text PDF
March 2007

Two-dimensional electrophoresis protein profiling and identification in rat bronchoalveolar lavage fluid following allergen and endotoxin challenge.

Proteomics 2004 Jul;4(7):2101-10

Novartis Institutes for Biomedical Research, Central Technologies-Analytical & Imaging Sciences Unit, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004

Magnetic resonance imaging in drug discovery: lessons from disease areas.

Drug Discov Today 2004 Jan;9(1):35-42

Novartis Institutes for BioMedical Research, Discovery Technologies, Analytics and Imaging Sciences Unit, Lichstr. 35, WSJ-386.209, CH-4002 Basel Switzerland.

View Article and Find Full Text PDF
January 2004

Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging.

Eur J Pharmacol 2003 Dec;482(1-3):319-24

Discovery Technologies Center, Novartis Institutes for BioMedical Research, Lichstr. 35, WSJ-386.2.09, CH-4002, Basel, Switzerland.

View Article and Find Full Text PDF
December 2003

Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs.

Trends Pharmacol Sci 2003 Oct;24(10):550-4

Discovery Technologies Center, Novartis Institutes for BioMedical Research, Lichtstrasse 35, WSJ-386.2.09, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
October 2003

Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging.

Br J Pharmacol 2003 Sep 18;140(2):239-46. Epub 2003 Aug 18.

Novartis Institutes for Biomedical Research, Central Technologies, Analytics and Imaging Sciences Unit, Lichtstr. 35, WSJ-386.2.09 CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
September 2003

Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen.

Naunyn Schmiedebergs Arch Pharmacol 2003 Jul 24;368(1):17-25. Epub 2003 Jun 24.

Novartis Institute for Biomedical Research, WSJ.386.508, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2003

Suppression of adenosine A(3) receptor-mediated hypotension and mast cell degranulation in the rat by dexamethasone.

J Pharmacol Exp Ther 2002 Aug;302(2):725-30

Research Department, Novartis Pharma AG, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
August 2002

Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI.

Am J Physiol Lung Cell Mol Physiol 2002 Jul;283(1):L22-30

Central Technologies, Novartis Pharma, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2002

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

Eur J Pharmacol 2002 Mar;438(3):183-8

Research Department, Novartis Pharma AG, WSJ-386.510, CH-4002, Basel, Switzerland.

View Article and Find Full Text PDF
March 2002

Pulmonary inflammation monitored noninvasively by MRI in freely breathing rats.

Biochem Biophys Res Commun 2002 Mar;292(1):216-21

Central Technologies, Novartis Pharma AG, Lichtstrasse 35, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
March 2002